• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直流电复律后维持窦性心律的新型药物干预措施。

Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.

作者信息

Thomas D E, Yousef Z, Anderson R A

机构信息

The Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN Wales, UK.

出版信息

ISRN Cardiol. 2011;2011:176834. doi: 10.5402/2011/176834. Epub 2011 Jul 12.

DOI:10.5402/2011/176834
PMID:22347630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3262493/
Abstract

Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates of atrial fibrillation. In recent years, several adjunctive therapies have emerged which may facilitate the maintenance of sinus rhythm. These novel therapies and their potential mechanisms of action are reviewed in this article.

摘要

尽管有针对心房颤动的潜在治愈性干预措施,但传统抗心律失常治疗以及抗凝与直流电复律相结合仍发挥着重要作用。不幸的是,后一种方法受到心房颤动高复发率的干扰。近年来,出现了几种辅助治疗方法,可能有助于维持窦性心律。本文对这些新疗法及其潜在作用机制进行了综述。

相似文献

1
Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.直流电复律后维持窦性心律的新型药物干预措施。
ISRN Cardiol. 2011;2011:176834. doi: 10.5402/2011/176834. Epub 2011 Jul 12.
2
Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.胺碘酮用于直流电复律失败后慢性心房颤动患者窦性心律的恢复与维持。
Clin Cardiol. 1997 Apr;20(4):337-40. doi: 10.1002/clc.4960200407.
3
Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.心房颤动和心房扑动直流电复律后窦性心律维持的预测因素:基于近期获取数据的再分析
Cardiology. 1996 May-Jun;87(3):181-8. doi: 10.1159/000177084.
4
[Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].[心房颤动/心房扑动直流电复律后窦性心律维持的预测因素]
Ugeskr Laeger. 2005 Sep 5;167(36):3408-12.
5
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.心房颤动的药物复律:当前的管理与治疗选择
Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003.
6
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.房颤直流电复律后,口服维拉帕米进行临时复律前治疗并不能改善窦性心律维持情况。
Heart. 2004 May;90(5):534-8. doi: 10.1136/hrt.2003.017707.
7
Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5-year follow-up of 268 consecutive patients.心房颤动或心房扑动患者电复律后窦性心律维持不佳:268例连续患者的5年随访
Scand Cardiovasc J. 2003 Dec;37(6):324-8. doi: 10.1080/14017430310016090.
8
High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.甲状腺毒症后慢性心房颤动患者心脏复律后窦性心律维持率高。
Int J Cardiol. 1987 Jul;16(1):47-55. doi: 10.1016/0167-5273(87)90269-5.
9
CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.CHA2DS2-VASc评分在预测电复律或药物复律后早期房颤复发中的应用
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):636-41. doi: 10.2459/JCM.0000000000000139.
10
[Pharmacological therapy of atrial fibrillation and atrial flutter].[心房颤动和心房扑动的药物治疗]
Herz. 2002 Jun;27(4):329-44. doi: 10.1007/s00059-002-2390-7.

本文引用的文献

1
Valsartan for prevention of recurrent atrial fibrillation.缬沙坦预防心房颤动复发
N Engl J Med. 2009 Apr 16;360(16):1606-17. doi: 10.1056/NEJMoa0805710.
2
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.在血压正常的患者中,血管紧张素转换酶抑制剂雷米普利预防孤立性房颤复发的研究。
J Am Coll Cardiol. 2009 Jan 6;53(1):24-9. doi: 10.1016/j.jacc.2008.08.071.
3
Does treatment with ACE inhibitors prevent the long term recurrences of lone atrial fibrillation after cardioversion?血管紧张素转换酶抑制剂治疗能否预防心脏复律后孤立性房颤的长期复发?
Rom J Intern Med. 2007;45(1):29-33.
4
Candesartan in the prevention of relapsing atrial fibrillation.坎地沙坦预防复发性心房颤动
Int J Cardiol. 2007 Aug 9;120(1):85-91. doi: 10.1016/j.ijcard.2006.08.086. Epub 2006 Nov 17.
5
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年心房颤动患者管理指南——执行摘要:美国心脏病学会/美国心脏协会实践指南工作组及欧洲心脏病学会实践指南委员会(修订2001年心房颤动患者管理指南写作委员会)报告
J Am Coll Cardiol. 2006 Aug 15;48(4):854-906. doi: 10.1016/j.jacc.2006.07.009.
6
Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure.选择性醛固酮阻断可抑制心力衰竭患者的房性快速心律失常。
J Cardiovasc Electrophysiol. 2006 May;17(5):534-41. doi: 10.1111/j.1540-8167.2006.00372.x.
7
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.螺内酯可减轻心肌梗死大鼠心力衰竭时扩张心房的纤维化。
Eur Heart J. 2005 Oct;26(20):2193-9. doi: 10.1093/eurheartj/ehi478. Epub 2005 Sep 1.
8
Mechanism for atrial tachyarrhythmia in chronic volume overload-induced dilated atria.
J Cardiovasc Electrophysiol. 2005 Jul;16(7):760-9. doi: 10.1046/j.1540-8167.2005.40331.x.
9
N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.N-3脂肪酸预防冠状动脉搭桥术后房颤:一项随机对照试验。
J Am Coll Cardiol. 2005 May 17;45(10):1723-8. doi: 10.1016/j.jacc.2005.02.079.
10
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.原发性醛固酮增多症患者心血管事件发生率增加的证据。
J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8. doi: 10.1016/j.jacc.2005.01.015.